USD 7.34
(-4.43%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -592 Million USD | -179.25% |
2022 | -212 Million USD | 77.37% |
2021 | -937 Million USD | -67.62% |
2020 | -559 Million USD | 68.65% |
2019 | -1.78 Billion USD | 57.02% |
2018 | -4.14 Billion USD | -272.55% |
2017 | 2.4 Billion USD | 199.79% |
2016 | -2.4 Billion USD | -804.96% |
2015 | -266.2 Million USD | -129.14% |
2014 | 913.5 Million USD | 205.47% |
2013 | -866.14 Million USD | -646.51% |
2012 | -116.02 Million USD | -172.72% |
2011 | 159.55 Million USD | 176.64% |
2010 | -208.19 Million USD | -217.99% |
2009 | 176.45 Million USD | -11.73% |
2008 | 199.9 Million USD | 2.23% |
2007 | 195.53 Million USD | -4.12% |
2006 | 203.93 Million USD | 129.07% |
2005 | 89.02 Million USD | 68.78% |
2004 | 52.74 Million USD | 293.46% |
2003 | -27.26 Million USD | -131.06% |
2002 | 87.79 Million USD | 0.4% |
2001 | 87.44 Million USD | 159.1% |
2000 | -147.97 Million USD | -336.76% |
1999 | 62.5 Million USD | 37.67% |
1998 | 45.4 Million USD | 28.98% |
1997 | 35.2 Million USD | 55.07% |
1996 | 22.7 Million USD | 284.75% |
1995 | 5.9 Million USD | -37.89% |
1994 | 9.5 Million USD | 143.59% |
1993 | 3.9 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -63.71 Million USD | -116.13% |
2024 Q2 | 10 Million USD | 115.7% |
2024 Q3 | -85 Million USD | -950.0% |
2023 Q1 | -209 Million USD | 49.02% |
2023 Q2 | 26 Million USD | 112.44% |
2023 Q3 | -378 Million USD | -1553.85% |
2023 FY | -592 Million USD | -179.25% |
2023 Q4 | 395 Million USD | 204.5% |
2022 Q2 | -139 Million USD | -110.61% |
2022 Q3 | 399 Million USD | 387.05% |
2022 FY | -212 Million USD | 77.37% |
2022 Q4 | -410 Million USD | -202.76% |
2022 Q1 | -66 Million USD | -195.65% |
2021 Q4 | 69 Million USD | -63.3% |
2021 FY | -937 Million USD | -67.62% |
2021 Q1 | -610 Million USD | -298.69% |
2021 Q3 | 188 Million USD | 131.6% |
2021 Q2 | -595 Million USD | 2.46% |
2020 Q2 | -326 Million USD | -114.47% |
2020 Q4 | -153 Million USD | -315.49% |
2020 FY | -559 Million USD | 68.65% |
2020 Q1 | -152 Million USD | 89.97% |
2020 Q3 | 71 Million USD | 121.78% |
2019 Q4 | -1.51 Billion USD | -2993.88% |
2019 Q3 | -49 Million USD | 71.35% |
2019 Q2 | -171 Million USD | -228.85% |
2019 Q1 | -52 Million USD | 84.88% |
2019 FY | -1.78 Billion USD | 57.02% |
2018 FY | -4.14 Billion USD | -272.55% |
2018 Q1 | -2.69 Billion USD | -624.95% |
2018 Q2 | -873 Million USD | 67.58% |
2018 Q3 | -350 Million USD | 59.91% |
2018 Q4 | -344 Million USD | 1.71% |
2017 Q2 | -38 Million USD | -106.05% |
2017 Q3 | 1.3 Billion USD | 3523.68% |
2017 Q4 | 513 Million USD | -60.57% |
2017 FY | 2.4 Billion USD | 199.79% |
2017 Q1 | 628 Million USD | 221.94% |
2016 Q2 | -302.3 Million USD | 19.11% |
2016 FY | -2.4 Billion USD | -804.96% |
2016 Q4 | -515 Million USD | 57.73% |
2016 Q3 | -1.21 Billion USD | -303.04% |
2016 Q1 | -373.7 Million USD | -11.09% |
2015 FY | -266.2 Million USD | -129.14% |
2015 Q4 | -336.4 Million USD | -779.6% |
2015 Q1 | 73.7 Million USD | -86.22% |
2015 Q2 | -53 Million USD | -171.91% |
2015 Q3 | 49.5 Million USD | 193.4% |
2014 Q4 | 534.9 Million USD | 94.23% |
2014 Q1 | -22.6 Million USD | -118.26% |
2014 Q2 | 125.8 Million USD | 656.64% |
2014 FY | 913.5 Million USD | 205.47% |
2014 Q3 | 275.4 Million USD | 118.92% |
2013 Q4 | 123.76 Million USD | 112.72% |
2013 FY | -866.14 Million USD | -646.51% |
2013 Q3 | -973.24 Million USD | -9111.51% |
2013 Q2 | 10.8 Million USD | 139.23% |
2013 Q1 | -27.53 Million USD | 69.12% |
2012 Q2 | -21.6 Million USD | -67.22% |
2012 Q4 | -89.14 Million USD | -1266.02% |
2012 Q1 | -12.92 Million USD | -123.13% |
2012 Q3 | 7.64 Million USD | 135.38% |
2012 FY | -116.02 Million USD | -172.72% |
2011 Q1 | 6.48 Million USD | 120.82% |
2011 Q3 | 40.86 Million USD | -27.5% |
2011 Q4 | 55.85 Million USD | 36.69% |
2011 FY | 159.55 Million USD | 176.64% |
2011 Q2 | 56.36 Million USD | 769.48% |
2010 Q3 | -207.88 Million USD | -711.98% |
2010 Q2 | 33.96 Million USD | 1178.38% |
2010 Q4 | -31.13 Million USD | 85.03% |
2010 FY | -208.19 Million USD | -217.99% |
2010 Q1 | -3.15 Million USD | -104.32% |
2009 Q2 | 24.09 Million USD | -38.24% |
2009 FY | 176.45 Million USD | -11.73% |
2009 Q1 | 39 Million USD | -67.6% |
2009 Q4 | 73 Million USD | 80.86% |
2009 Q3 | 40.36 Million USD | 67.55% |
2008 FY | 199.9 Million USD | 2.23% |
2008 Q4 | 120.38 Million USD | 148.53% |
2008 Q3 | 48.43 Million USD | 291.53% |
2008 Q2 | -25.28 Million USD | -144.86% |
2008 Q1 | 56.37 Million USD | 276.33% |
2007 Q1 | 93.81 Million USD | -18.64% |
2007 Q2 | 67.82 Million USD | -27.71% |
2007 FY | 195.53 Million USD | -4.12% |
2007 Q3 | 65.86 Million USD | -2.89% |
2007 Q4 | -31.97 Million USD | -148.54% |
2006 FY | 203.93 Million USD | 129.07% |
2006 Q4 | 115.3 Million USD | 304.26% |
2006 Q3 | -56.45 Million USD | -166.2% |
2006 Q2 | 85.27 Million USD | 24.61% |
2006 Q1 | 68.43 Million USD | 349.08% |
2005 Q3 | 101.66 Million USD | 2642.46% |
2005 Q4 | -27.47 Million USD | -127.03% |
2005 FY | 89.02 Million USD | 68.78% |
2005 Q2 | 3.7 Million USD | -66.7% |
2005 Q1 | 11.13 Million USD | 117.9% |
2004 Q4 | -62.2 Million USD | -225.32% |
2004 Q1 | 21.1 Million USD | 120.65% |
2004 Q3 | 49.63 Million USD | 12.28% |
2004 Q2 | 44.2 Million USD | 109.46% |
2004 FY | 52.74 Million USD | 293.46% |
2003 Q3 | 12.98 Million USD | 1383.1% |
2003 FY | -27.26 Million USD | -131.06% |
2003 Q1 | 57.59 Million USD | 156.04% |
2003 Q4 | -102.22 Million USD | -887.29% |
2003 Q2 | -1.01 Million USD | -101.76% |
2002 Q3 | 74.97 Million USD | 19.85% |
2002 Q1 | 53.05 Million USD | 380.37% |
2002 FY | 87.79 Million USD | 0.4% |
2002 Q4 | -102.79 Million USD | -237.1% |
2002 Q2 | 62.55 Million USD | 17.92% |
2001 Q2 | 44.1 Million USD | 51.21% |
2001 FY | 87.44 Million USD | 159.1% |
2001 Q1 | 29.16 Million USD | 147.99% |
2001 Q4 | -18.92 Million USD | -157.16% |
2001 Q3 | 33.1 Million USD | -24.95% |
2000 Q4 | -60.77 Million USD | 40.8% |
2000 Q3 | -102.64 Million USD | -559.44% |
2000 Q1 | -6.89 Million USD | -127.59% |
2000 FY | -147.97 Million USD | -336.76% |
2000 Q2 | 22.34 Million USD | 423.89% |
1999 Q2 | 10.87 Million USD | 46.2% |
1999 Q1 | 7.43 Million USD | -49.76% |
1999 Q3 | 17.1 Million USD | 57.31% |
1999 Q4 | 25 Million USD | 46.2% |
1999 FY | 62.5 Million USD | 37.67% |
1998 Q2 | 9.5 Million USD | 21.79% |
1998 Q4 | 14.8 Million USD | 12.12% |
1998 FY | 45.4 Million USD | 28.98% |
1998 Q1 | 7.8 Million USD | -40.91% |
1998 Q3 | 13.2 Million USD | 38.95% |
1997 Q3 | 9.4 Million USD | 32.39% |
1997 FY | 35.2 Million USD | 55.07% |
1997 Q2 | 7.1 Million USD | 26.79% |
1997 Q1 | 5.6 Million USD | -5.08% |
1997 Q4 | 13.2 Million USD | 40.43% |
1996 Q4 | 5.9 Million USD | -6.35% |
1996 Q1 | 4.69 Million USD | 46.74% |
1996 FY | 22.7 Million USD | 284.75% |
1996 Q2 | 5.8 Million USD | 23.52% |
1996 Q3 | 6.3 Million USD | 8.62% |
1995 Q2 | 400 Thousand USD | -66.67% |
1995 Q1 | 1.2 Million USD | 200.0% |
1995 Q3 | 1 Million USD | 150.0% |
1995 Q4 | 3.2 Million USD | 220.0% |
1995 FY | 5.9 Million USD | -37.89% |
1994 Q4 | 400 Thousand USD | 0.0% |
1994 Q1 | 2.5 Million USD | 0.0% |
1994 Q2 | -2 Million USD | -180.0% |
1994 Q3 | 400 Thousand USD | 120.0% |
1994 FY | 9.5 Million USD | 143.59% |
1993 FY | 3.9 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Amneal Pharmaceuticals, Inc. | -83.99 Million USD | -604.821% |
Catalent, Inc. | -1.04 Billion USD | 43.241% |
Emergent BioSolutions Inc. | -760.5 Million USD | 22.156% |
Elanco Animal Health Incorporated | -1.23 Billion USD | 51.909% |
Perrigo Company plc | -12.7 Million USD | -4561.417% |
Teva Pharmaceutical Industries Limited | -559 Million USD | -5.903% |
Zoetis Inc. | 2.34 Billion USD | 125.256% |